Last updated: 11/07/2018 04:54:37
Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Trial overview
Official title: Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
Trial description: The objective of this study is to compare readmission to the emergency department for asthma in asthma patients who receive treatment with fluticasone propionate and salmeterol oral inhaler after an initial emergency department visit using a retrospective observational cohort study design.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Number of participants with an asthma-related event occurring between 1 and 6 months following the index event
Timeframe: Data were collected during a 4-year period from January 1, 2004 to December 31, 2008.
Secondary outcomes:
Not applicable
Interventions:
Drug: Fluticasone propionate/salmeterol combination ED MD
Drug: Fluticasone propionate/salmeterol combination OP MD
Enrollment:
6139
Observational study model:
Cohort
Primary completion date:
2010-01-07
Time perspective:
Retrospective
Clinical publications:
Stanford RH, Buikema AR, Riedel AA, Camargo Jr. CA, Gomez-Rey G, Chapman KR. Use of Fluticisone Propionate and Salmeterol in Combination Following Emergency Department Visit and Association with Reduction in Future Repeat Emergency Department Visits. Respir Med. 2012;106(12):1631-38
Medical condition
Asthma
Product
fluticasone propionate, fluticasone propionate/salmeterol, salmeterol
Collaborators
Not applicable
Study date(s)
June 2009 to July 2010
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
12+ years
Accepts healthy volunteers
No
- Subjects with asthma as determined by ICD-9 codes and asthma drug use
- at least 12 years of age
- Subjects with COPD or treatment for COPD
Inclusion and exclusion criteria
Inclusion criteria:
- Subjects with asthma as determined by ICD-9 codes and asthma drug use
- at least 12 years of age
- discharged from an initial Emergency Department visit within 12 months
Exclusion criteria:
- Subjects with COPD or treatment for COPD
Trial location(s)
No location data available.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Finalized
Actual primary completion date
2010-01-07
Actual study completion date
2010-01-07
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website